# Kova reviews (2026): GLP-1 telehealth sellers | This GLP Kova combines clinician-reviewed treatment with an app for tracking progress. Its plan billing can continue independently of refill and review timing. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/kova Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated October 2026 Care tracking with contract commitments # Kova review Kova combines clinician-reviewed treatment with an app for tracking progress. Its plan billing can continue independently of refill and review timing. ## The verdict The tracking tools may support a continuing conversation, but they are not the clinician. Pay particular attention to the separation between recurring billing and clinical reviews: delayed intake or an unused refill does not automatically pause the plan. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection Prescription Required Compounded Yes — not FDA-approved Kova is a telehealth platform with semaglutide and tirzepatide programs and a companion app for weight, nutrition and symptom tracking. 1. ## Who writes the prescription, and what do they see? Independent providers make prescription and renewal decisions. The terms say the company and app cannot prescribe, recommend or change a dose; patient-entered logs do not by themselves amend a treatment plan. Patients complete an assessment and access a provider portal. The program describes ongoing check-ins, while its legal terms make patients responsible for completing required refill and review steps. 2. ## What happens when the dose goes up? Clinical eligibility and later prescription decisions remain separate from the subscription. Ask how frequently a clinician reviews tracking entries and what happens to billing when treatment is paused or changed. 3. ## What the price includes The site separates introductory one-month prices from renewal rates and discounted longer plans. The contract also permits fixed-term commitments paid monthly, so monthly billing does not necessarily mean month-to-month cancellation. 4. ## What it claims, and what it cites The public program identifies [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) and [tirzepatide](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) and discusses compounded versions. Compounded medicines are not FDA-approved; branded-trial averages on the site are not proof of equivalent program outcomes. ## Where it holds up, and where it does not - Strength: App supports symptom and progress tracking - Strength: Independent clinical decisions stated - Limitation: Billing can precede refill review - Limitation: Tracking is not a clinical response guarantee ## What the evidence says about this kind of treatment The assessment above is about Kova. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for Someone who wants app-based tracking and is willing to read the full plan commitment. Wrong for Someone expecting that skipping a refill automatically stops their charges. ## The evidence behind what Kova prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Kova compares | Seller | Who it suits | Go | | --- | --- | --- | | SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | | | ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | | | RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Onyx Weight Loss](https://thisglp.com/reviews/onyx-weight-loss) [Open Water Rx](https://thisglp.com/reviews/open-water-rx) [Optimized Health](https://thisglp.com/reviews/optimized-health) [Options Medical Weight Loss](https://thisglp.com/reviews/options-medical-weight-loss) [OrderlyMeds](https://thisglp.com/reviews/orderlymeds) [Oria Meds](https://thisglp.com/reviews/oria-meds) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Does entering a symptom in the app change my prescription? No. Kova’s terms distinguish tracking tools from independent provider decisions. Contact the care team about treatment changes. Does a missed refill request pause the plan? The terms say it does not, by itself, stop the billing cycle. ## Sources for this review Provider information checked October 26, 2026. Terms can change. - [Official service overview](https://trykova.com/) - [Official program and terms](https://trykova.com/terms/) Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).